MDL Judge Denies Interlocutory Appeal Of AndroGel Failure-To- Warn Preemption Issue

(September 19, 2017, 11:19 AM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on Sept. 18 denied a motion by defendants AbbVie Inc. and Abbott Laboratories to certify for interlocutory appeal...
To view the full article, register now.